pubmed-article:11306792 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0019693 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0015967 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0029921 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0019993 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0007561 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C0332189 | lld:lifeskim |
pubmed-article:11306792 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:11306792 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:11306792 | pubmed:dateCreated | 2001-4-18 | lld:pubmed |
pubmed-article:11306792 | pubmed:abstractText | Patients with hematooncological disease or HIV infection and febrile episodes are usually treated in hospital with broad-spectrum antibiotics. The aim of this observational study was to assess the feasibility of ambulatory parenteral antibiotic therapy in hematooncological or HIV-infected patients with confirmed or suspected infection. | lld:pubmed |
pubmed-article:11306792 | pubmed:language | eng | lld:pubmed |
pubmed-article:11306792 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11306792 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11306792 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11306792 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11306792 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11306792 | pubmed:issn | 0009-3157 | lld:pubmed |
pubmed-article:11306792 | pubmed:author | pubmed-author:GüntherHH | lld:pubmed |
pubmed-article:11306792 | pubmed:author | pubmed-author:MüllerII | lld:pubmed |
pubmed-article:11306792 | pubmed:author | pubmed-author:HoA DAD | lld:pubmed |
pubmed-article:11306792 | pubmed:author | pubmed-author:GoldschmidtHH | lld:pubmed |
pubmed-article:11306792 | pubmed:author | pubmed-author:EgererGG | lld:pubmed |
pubmed-article:11306792 | pubmed:author | pubmed-author:KarthausMM | lld:pubmed |
pubmed-article:11306792 | pubmed:copyrightInfo | Copyright 2001 S. Karger AG, Basel | lld:pubmed |
pubmed-article:11306792 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11306792 | pubmed:volume | 47 | lld:pubmed |
pubmed-article:11306792 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11306792 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11306792 | pubmed:pagination | 219-25 | lld:pubmed |
pubmed-article:11306792 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:meshHeading | pubmed-meshheading:11306792... | lld:pubmed |
pubmed-article:11306792 | pubmed:articleTitle | Ceftriaxone for the treatment of febrile episodes in nonneutropenic patients with hematooncological disease or HIV infection: comparison of outpatient and inpatient care. | lld:pubmed |
pubmed-article:11306792 | pubmed:affiliation | Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. gerline_egerer@med.uni-heidelberg.de | lld:pubmed |
pubmed-article:11306792 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11306792 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:11306792 | pubmed:publicationType | Comparative Study | lld:pubmed |